Search tool

Despite a continued decline in injecting drug use over the past decade in Europe, this behaviour is still responsible for a disproportionate level of health harms. On this page, you can find...

MDMA is a synthetic drug chemically related to the amphetamines, but with somewhat different effects. In Europe, MDMA use has generally been associated with episodic patterns of consumption in the context of...

Alongside the more well-known substances available on illicit drugs markets, a number of other substances with hallucinogenic, anaesthetic, dissociative or depressant properties are used in Europe: these include LSD, hallucinogenic mushrooms, ketamine...

Amphetamine, methamphetamine and, more recently, synthetic cathinones are all synthetic central nervous system stimulants available on the drug market in Europe. On this page, you can find the latest analysis of the...

People who inject drugs are at risk of contracting infections through the sharing of drug use paraphernalia. On this page, you can find the latest analysis of drug-related infectious diseases in Europe...

An analysis of the supply-related indicators available on the commonly used illicit drugs in the European Union suggests that availability remains high across all substance types. On this page, you can find...

The market for new psychoactive substances is characterised by the large number of substances that have appeared in this area and that new compounds continue to be detected each year. On this...

Drug-induced deaths are those that are directly attributable to the use of drugs. On this page, you can find the latest analysis of drug-induced deaths in Europe, including key data on overdose...

Opioid users represent the largest group undergoing specialised drug treatment, mainly in the form of opioid agonist treatment. On this page, you can find the latest analysis of the provision of opioid...

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by national partners.